EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab

Omar Ghanaiem iD, Gavriel Chaushu, Daya Masri

Oral Diseases · 2026-06 · 32 (6) · 1642-1651

DOI: 10.1111/odi.70030 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Oral Diseases, online erschienen am 14.07.2025. Verfasst von Omar Ghanaiem und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, the Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Denosumab, Bisphosphonate-Associated Osteonecrosis of the Jaw, Diphosphonates, Osteoporosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Medication‐Related Osteonecrosis of the Jaw (MRONJ) is a severe adverse effect of antiresorptive and antiangiogenic treatment, primarily in osteoporotic and oncologic patients. The disease is characterized by persistent jawbone necrosis that results in significant impairment of the quality of life of involved patients. The aim of this study is to compare the radiographic characteristics of MRONJ between osteoporotic and oncologic patients and assess the differences based on treatment type, particularly bisphosphonates and denosumab (RANK‐L inhibitors).

Methods

A retrospective analysis of 152 MRONJ patients (41 osteoporotic, 111 oncologic) from Rabin‐Bilinson Medical Center (2014–2024) examined radiographic features—lytic changes, sclerosis, periosteal reactions, sequestration, and periodontal ligament destruction—using panoramic radiography, CBCT, and MDCT.

Results

Sclerosis was more frequent in osteoporotic patients compared to oncologic patients ( p < 0.05). No statistically significant differences were found in other radiographic features. Bisphosphonate‐induced MRONJ was more frequently accompanied by sclerosis compared to denosumab‐related cases in osteoporotic patients ( p = 0.0318), while no significant differences were found in the oncologic group.

Conclusions

Most of the radiographic features of MRONJ were similar in osteoporotic and oncologic patients. However, sclerosis was more common in osteoporotic patients exposed to Bisphosphonates, which may be due to their prolonged exposure to antiresorptive drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DenosumabBisphosphonate-Associated Osteonecrosis of the JawDiphosphonatesOsteoporosisBone Density Conservation AgentsNeoplasmsHumansFemaleRetrospective StudiesMaleAgedMiddle AgedAged, 80 and overRadiography, PanoramicCone-Beam Computed Tomography

Stichwörter der Autor:innen

MRONJbisphosphonatesdenosumabosteonecrosisradiographic features

Substanzen

DenosumabDiphosphonatesBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, the Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Oral and Maxillofacial Surgery, Rabin Medical Center, Petah Tikva, Israel.

ORCID-Profile: Omar Ghanaiem

Zitieren

APA

Ghanaiem, O., Chaushu, G., & Masri, D. (2026). Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab. Oral Diseases, 32(6), 1642-1651. https://doi.org/10.1111/odi.70030

Vancouver

Ghanaiem O, Chaushu G, Masri D. Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab. Oral Diseases. 2026;32(6):1642-1651. doi:10.1111/odi.70030

BibTeX
@article{Ghanaiem2026,
  author = {Ghanaiem, Omar and Chaushu, Gavriel and Masri, Daya},
  title = {Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab},
  journal = {Oral Diseases},
  year = {2026},
  volume = {32},
  number = {6},
  pages = {1642--1651},
  doi = {10.1111/odi.70030}
}
Kostenlos starten →